EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $214,000 | -2.7% | 4,329 | 0.0% | 0.00% | – |
| Q4 2021 | $220,000 | -9.1% | 4,329 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $242,000 | +30.8% | 4,329 | 0.0% | 0.00% | – |
| Q2 2021 | $185,000 | +2.8% | 4,329 | 0.0% | 0.00% | – |
| Q1 2021 | $180,000 | -10.9% | 4,329 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $202,000 | +9.8% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $184,000 | -11.5% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $208,000 | +4.5% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $199,000 | -23.5% | 4,329 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $260,000 | -35.5% | 4,329 | -39.2% | 0.00% | 0.0% |
| Q3 2019 | $403,000 | +219.8% | 7,120 | +216.4% | 0.00% | – |
| Q2 2019 | $126,000 | +10.5% | 2,250 | 0.0% | 0.00% | – |
| Q1 2019 | $114,000 | +26.7% | 2,250 | 0.0% | 0.00% | – |
| Q4 2018 | $90,000 | -42.3% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $156,000 | – | 2,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |